EN DE
Watch Limoneira Co for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Limoneira Co (LMNR) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Limoneira Co stock $12.38, price $10.64, upside +16.4%, quality 30 out of 100. Rating: undervalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive US

LC Limoneira Co logo Thin data Nov 7, 2026

Limoneira Co

LMNR · US
Speculative

The stock costs 14% less than our calculation considers fair.

Fair value $12.38 · Undervalued
Low debt
1.4% dividend yield · Watch coverage
Insiders sold $75,218 (6M)
Quality 30/100
Weak Growth (revenue 5y −0.6 %/yr in USD)
Loss-making · -33.0% net margin (TTM)
Negative free cash flow
Trails peers (2/12)
Narrow moat 16/100
Thin data
⟳ Cyclical
Watch Limoneira Co for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$28.25 $9.94 Fair Value $12.38 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range $9.94 – $28.25 · fair‑value band $9.24 – $18.46 · the $10.64 price screens below the $12.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Limoneira Co in your weekly email

Every Wednesday you see whether Limoneira Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Limoneira Company operates as an agribusiness company in the United States and internationally. The company operates through four segments: Fresh Lemons, Lemon Packing, Avocados, and Other Agribusiness. It produces, processes, harvests, and packs oranges, specialty citrus, and wine grapes.

Show moreShow less

The company also rents residential housing units and commercial office buildings, as well as leases land to third-party agricultural tenants.

In addition, it is involved in the organic recycling operations; provision of farm management services; and development of land parcels, multi-family housing, and single-family homes.

The company markets and sells its lemons directly to food service, wholesale, and retail customers; avocados, oranges, specialty citrus, and other crops to third-party packing houses; and wine grapes to wine producers.

Limoneira Company was founded in 1893 and is headquartered in Santa Paula, California.

Stock analysis

Limoneira Co (LMNR) currently trades at $10.64, while our model-based Fair Value estimate is $12.38, implying the stock looks roughly 14% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 87/100, which puts the data coverage at low.

Scenario range: $9.24 (bear) to $18.46 (bull), the price of $10.64 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Limoneira Co reported revenue of $160M in FY2025 versus $166M in FY2021, a compound −1.0%/yr. Reported net income was −$16.0M in FY2025.

Key figures

Market cap $191M Micro · P/S ratio 1.49 · EPS (TTM) $−2.41 · Dividend yield 1.4% · Net margin −33.0% · Return on equity −24.8% · Return on assets (EBIT) −1.7% (5-year average) · Operating margin 3.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (medium confidence).

What moves the price

The share trades about 29% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at 16%, LMNR screens cheaper than that median.

Fair Value models

Bear $9.24 Fair Value $12.38 Bull $18.46
Price $10.64 · Upside +16.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $4.62 $6.19 $9.23 54
All 1 models by family
Asset-Based
NCAV (Graham) $4.62 $6.19 $9.23 54

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 30/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 0
Are margins and returns getting better?
Cashflow 1
Do the profits arrive as real cash?
Financial strength 41
Debt, balance sheet and risk of trouble
Investment 88
Does it invest with discipline instead of growing at any price?
Low Volatility 81
How calm the share price moves, does not count
Price momentum 19
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 9
Distance to the 52-week high, does not count
New shares 75
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $75,218 and none bought.

  • SaleGregory C. HammVP, CFO and Treasurer9× since Mar 3, 2026: 9,000 shares, avg. $12.82$115,378Nov 2, 202610b5-1 plan
  • BuyScott S SlaterDirector5,000 shares at $12.85$64,250Jan 8, 2026
  • BuyPeter J NolanDirector20,000 shares at $12.74$254,779Jan 5, 2026

Plus 2 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 3/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−16.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
Start year 2020 (pandemic). Over 10 years: +4.8% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−11.2% (2020) → −15.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch LMNR, get fair value alerts →

Compare Limoneira Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 291 stocks

Beats the industry median on 2/11 measures
Overall it trails its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside +16.4% · Above median
Profitability
Return on assets −5.0% · Bottom 25%
Net margin (12 months) −33.0% · Bottom 25%
Operating margin (12 months) 3.4% · Below median
Growth and dividend
Revenue growth (quarter YoY) −7.7% · Bottom 25%
Dividend yield (12 months) 1.4% · Below median
Balance sheet
Debt / equity 0.42× · Highest 25%

Valuation Multiplesvs Farm Products median · lower = cheaper

P/B 1.11× · Cheaper than median
P/S (12 months) 1.48× · Pricier than median
PEG 5.92× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)55 · sector 27
FUTURE (revenue growth)0 · sector 15
PAST (return on equity)0 · sector 17
HEALTH (low debt)79 · sector 94
DIVIDEND (yield)28 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Charoen Pokphand Foods Public Company CPF 20.10 THB 40.78 THB +103% vs LMNR
Mowi ASA MOWI kr 218.00 kr 273.41 +25% vs LMNR
Tyson Foods, Inc TSN $59.68 $73.24 +23% vs LMNR
Muyuan Foods Group 002714 ¥44.40 ¥53.02 +19% vs LMNR
United Plantations Berhad 2089 30.38 MYR 33.42 MYR +10% vs LMNR
Archer-Daniels-Midland Company ADM $69.97 $61.55 −12% vs LMNR
Wens Foodstuff Group 300498 ¥16.82 ¥12.08 −28% vs LMNR
Fujian Wanchen Food Group 300972 ¥129.60 ¥88.62 −32% vs LMNR
Bunge Global SA BG $99.10 $56.81 −43% vs LMNR
SalMar ASA SALM kr 572.50 kr 260.28 −55% vs LMNR

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Limoneira Co: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Limoneira Co Fair Value". https://www.fairvalue-calculator.com/stock/LMNR

Frequently asked questions

Is Limoneira Co (LMNR) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $12.38 versus a price of $10.64, about +16% upside (undervalued).
What is the fair value of LMNR?
Our model-based fair value for Limoneira Co is $12.38 (as of Nov 7, 2026), built from audited fundamentals. The current price: $10.64.
What is the quality score of LMNR?
Limoneira Co has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Limoneira Co (LMNR)?
Our model-based price target is the fair value of $12.38 (as of Nov 7, 2026) from 1 valuation models. Cautious scenario $9.24, optimistic scenario $18.46. It is a calculation from audited fundamentals, not an analyst target.
What is the Limoneira Co stock forecast for 2026?
Our models put fair value at $12.38, about +16% upside versus a price of $10.64 (undervalued). Cautious scenario $9.24, optimistic scenario $18.46. The calculation is refreshed regularly with new filings.
What is the revenue of Limoneira Co (LMNR)?
Limoneira Co reported trailing-twelve-month revenue of about $129M (latest available figure, as of Nov 7, 2026).
Does Limoneira Co pay a dividend?
Limoneira Co currently shows a dividend yield of 1.41% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Limoneira Co (LMNR) and when is the ex-dividend date?
Limoneira Co pays a dividend of $0.15 per share a year, a dividend yield of 1.4%. The last ex-dividend date was Dec 30, 2025. A dividend has been paid every year since at least 2008. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Limoneira Co (LMNR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Limoneira Co it is $12.38 per share (as of Nov 7, 2026), against a price of $10.64. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Limoneira Co stock overvalued or undervalued in 2026?
As of Nov 7, 2026, LMNR trades below its calculated fair value: price $10.64, fair value $12.38, a gap of about +16% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LMNR?
No. The price is what the market pays today ($10.64); the fair value is what the company's own numbers justify ($12.38). For Limoneira Co the two are $1.74 per share apart. That gap is exactly why we show both numbers side by side.
How much is Limoneira Co worth?
The market values Limoneira Co at about $191M (market capitalisation, as of Nov 7, 2026). Per share that is $10.64; our models calculate a fair value of $12.38 per share.
What do the bullish and bearish scenarios say about LMNR?
Our models span a range for Limoneira Co: cautious scenario $9.24, base $12.38, optimistic $18.46 per share (as of Nov 7, 2026, price $10.64). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of LMNR?
The PEG ratio of Limoneira Co is 5.92 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Limoneira Co (LMNR)?
Balance-sheet figures for Limoneira Co (as of Nov 7, 2026): return on equity −24.8%, debt of 0.42 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is LMNR from its 52-week high?
Limoneira Co trades at $10.64, about 29% below its 52-week high of $15.03 and 6% above the low of $10.06 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $12.38 is for.
Which stocks are comparable to Limoneira Co?
From the same area (Consumer Defensive) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Limoneira Co stock attractive at the current price?
The data as of Nov 7, 2026: price $10.64, calculated fair value $12.38 (+16%), Quality Score 30/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LMNR calculated?
We run Limoneira Co through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $12.38 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Limoneira Co currently trades 14% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Limoneira Co (LMNR)?
The closing price on Nov 6, 2026 was $10.64. Our model-based fair value is $12.38, about +16% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Limoneira Co right now?
A fairly wide model range ($9.24 to $18.46) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Limoneira Co

How large is the market capitalisation of Limoneira Co (LMNR)?
The market capitalisation of Limoneira Co is $191M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Limoneira Co (LMNR)?
The price-to-sales ratio of Limoneira Co is 1.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Limoneira Co (LMNR)?
Earnings per share at Limoneira Co are $−2.41. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Limoneira Co (LMNR)?
The dividend yield of Limoneira Co is 1.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Limoneira Co (LMNR)?
The net margin of Limoneira Co is −33.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Limoneira Co (LMNR)?
The return on equity (ROE) of Limoneira Co is −24.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Limoneira Co (LMNR)?
On an EBIT basis the return on assets of Limoneira Co is −1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Limoneira Co (LMNR)?
The operating margin of Limoneira Co is 3.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Limoneira Co (LMNR)?
Revenue at Limoneira Co is growing −7.7% versus a year earlier (3y avg −4.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Limoneira Co (LMNR)?
Earnings per share at Limoneira Co are growing +96.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Limoneira Co (LMNR) generate?
The free cash flow of Limoneira Co is −$19.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Limoneira Co (LMNR) carry?
The net debt of Limoneira Co is $73.0M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Limoneira Co in the live analysis

One click puts Limoneira Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.